AAAAAA
Results: 1-25/37
Authors:
Nemoto, K
Shibamoto, Y
Ohmagari, J
Baba, Y
Ebe, K
Ariga, H
Takai, Y
Ouchi, A
Sasai, K
Shinozaki, M
Tsujitani, M
Sakaguchi, M
Yamada, S
Sakamoto, K
Citation: K. Nemoto et al., Phase Ia study of a hypoxic cell sensitizer doranidazole (PR-350) in combination with conventional radiotherapy, ANTI-CANC D, 12(1), 2001, pp. 1-6
Authors:
Jeremic, B
Shibamoto, Y
Acimovic, L
Nikolic, N
Dagovic, A
Aleksandrovic, J
Radosavljevic-Asic, G
Citation: B. Jeremic et al., Second cancers occurring in patients with early stage non-small-cell lung cancer treated with chest radiation therapy alone, J CL ONCOL, 19(4), 2001, pp. 1056-1063
Authors:
Oya, N
Kokubo, M
Mizowaki, T
Shibamoto, Y
Nagata, Y
Sasai, K
Nishimura, Y
Tsuboyama, T
Toguchida, J
Nakamura, T
Hiraoka, M
Citation: N. Oya et al., Definitive intraoperative very high-dose radiotherapy for localized osteosarcoma in the extremities, INT J RAD O, 51(1), 2001, pp. 87-93
Authors:
Negoro, Y
Nagata, Y
Aoki, T
Mizowaki, T
Araki, N
Takayama, K
Kokubo, M
Yano, S
Koga, S
Sasai, K
Shibamoto, Y
Hiraoka, M
Citation: Y. Negoro et al., The effectiveness of an immobilization device in conformal radiotherapy for lung tumor: Reduction of respiratory tumor movement and evaluation of thedaily setup accuracy, INT J RAD O, 50(4), 2001, pp. 889-898
Authors:
Shibamoto, Y
Jeremic, B
Acimovic, L
Milicic, B
Nikolic, N
Citation: Y. Shibamoto et al., Influence of interfraction interval on the efficacy and toxicity of hyperfractionated radiotherapy in combination with concurrent daily chemotherapy in stage III non-small-cell lung cancer, INT J RAD O, 50(2), 2001, pp. 295-300
Authors:
Jeremic, B
Shibamoto, Y
Acimovic, L
Milicic, B
Milisavljevic, S
Nikolic, N
Dagovic, A
Aleksandrovic, J
Radosavljevic-Asic, G
Citation: B. Jeremic et al., Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non-small-cell lung cancer: A randomized trial, INT J RAD O, 50(1), 2001, pp. 19-25
Authors:
Shibamoto, Y
Zhou, L
Hatta, H
Mori, M
Nishimoto, S
Citation: Y. Shibamoto et al., In vivo evaluation of a novel antitumor prodrug, 1-(2 '-oxopropyl)-5-fluorouracil (OFU001), which releases 5-fluorouracil upon hypoxic irradiation, INT J RAD O, 49(2), 2001, pp. 407-413
Authors:
Jeremic, B
Shibamoto, Y
Igrutinovic, I
Citation: B. Jeremic et al., Absence of cervical radiation myelitis after hyperfractionated radiation therapy with and without concurrent chemotherapy for locally advanced, unresectable, nonmetastatic squamous cell carcinoma of the head and neck, J CANC RES, 127(11), 2001, pp. 687-691
Authors:
Jeremic, B
Shibamoto, Y
Grujicic, D
Stojanovic, M
Milicic, B
Nikolic, N
Dagovic, A
Aleksandrovic, J
Citation: B. Jeremic et al., Concurrent accelerated hyperfractionated radiation therapy and carboplatin/etoposide in patients with malignant glioma: long-term results of a phase II study, J NEURO-ONC, 51(2), 2001, pp. 133-141
Authors:
Shibamoto, Y
Sasai, K
Oya, N
Hiraoka, M
Citation: Y. Shibamoto et al., Intracranial germinoma: Radiation therapy with tumor volume-based dose selection, RADIOLOGY, 218(2), 2001, pp. 452-456
Authors:
Kokubo, M
Nishimura, Y
Shibamoto, Y
Sasai, K
Hosotani, R
Imamura, M
Hiraoka, M
Citation: M. Kokubo et al., Concurrent chemoradiotherapy combined with intraoperative radiotherapy forlocally advanced pancreatic cancer: A feasibility study, ONCOL REP, 7(4), 2000, pp. 773-776
Authors:
Matsuoka, H
Shibamoto, Y
Kubota, T
Tsujitani, M
Majima, T
Citation: H. Matsuoka et al., In vivo efficacy and pharmacokinetics of a new hypoxic cell radiosensitizer doranidazole in SUIT-2 human pancreatic cancer xenografted in mouse pancreas, ONCOL REP, 7(1), 2000, pp. 23-26
Authors:
Shibamoto, Y
Zhou, L
Hatta, H
Mori, M
Nishimoto, S
Citation: Y. Shibamoto et al., A novel class of antitumor prodrug, 1-(2 '-oxopropyl)-5-fluorouracil (OFU001), that releases 5-fluorouracil upon hypoxic irradiation, JPN J CANC, 91(4), 2000, pp. 433-438
Authors:
Jeremic, B
Shibamoto, Y
Milicic, B
Nikolic, N
Dagovic, A
Aleksandrovic, J
Vaskovic, Z
Tadic, L
Citation: B. Jeremic et al., Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial, J CL ONCOL, 18(7), 2000, pp. 1458-1464
Authors:
Kokubo, M
Nishimura, Y
Shibamoto, Y
Sasai, K
Kanamori, S
Hosotani, R
Imamura, M
Hiraoka, M
Citation: M. Kokubo et al., Analysis of the clinical benefit of intraoperative radiotherapy in patients undergoing macroscopically curative resection for pancreatic cancer, INT J RAD O, 48(4), 2000, pp. 1081-1087
Authors:
Mochizuki, E
Shibamoto, Y
Yano, K
Kanehisa, N
Kai, Y
Tagawa, S
Yamamoto, Y
Citation: E. Mochizuki et al., Crystal structures and solid-state reactivities of 1,4-and 1,2-bis(5-hydroxypenta-1,3-diynyl)benzenes and 1-(5-hydroxypenta-1,3-diynyl)-4-ethynylbenzene, J CHEM S P2, (1), 2000, pp. 155-159
Authors:
Shibamoto, Y
Kubota, T
Kishii, K
Tsujitani, M
Citation: Y. Shibamoto et al., Radiosensitivity of human pancreatic cancer cells in vitro and in vivo, and the effect of a new hypoxic cell sensitizer, doranidazole, RADIOTH ONC, 56(2), 2000, pp. 265-270
Authors:
Kokubo, M
Shibamoto, Y
Takahashi, JA
Sasai, K
Oya, N
Hashimoto, N
Hiraoka, M
Citation: M. Kokubo et al., Efficacy of conventional radiotherapy for recurrent meningioma, J NEURO-ONC, 48(1), 2000, pp. 51-55
Authors:
Kokubo, M
Sasai, K
Shibamoto, Y
Aoki, T
Oya, N
Mitsumori, M
Takahashi, JA
Hashimoto, N
Hiraoka, M
Citation: M. Kokubo et al., Long-term results of radiation therapy for pituitary adenoma, J NEURO-ONC, 47(1), 2000, pp. 79-84
Authors:
Aizawa, Y
Shibamoto, Y
Takagi, I
Zeniya, M
Toda, G
Citation: Y. Aizawa et al., Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C - A long term follow-up study after histologic diagnosis, CANCER, 89(1), 2000, pp. 53-59
Authors:
Jeremic, B
Shibamoto, Y
Milicic, B
Nikolic, N
Dagovic, A
Aleksandrovic, J
Vaskovic, Z
Tadic, L
Citation: B. Jeremic et al., Elective ipsilateral neck irradiation of patients with locally advanced maxillary sinus carcinoma, CANCER, 88(10), 2000, pp. 2246-2251
Authors:
Shibamoto, Y
Horii, N
Takahashi, M
Citation: Y. Shibamoto et al., Long-term control of multiple lung metastases from osteosarcoma obtained by conventional radiotherapy: A case report, ONCOL REP, 6(5), 1999, pp. 1085-1087
Authors:
Jeremic, B
Shibamoto, Y
Nikolic, N
Milicic, B
Milisavljevic, S
Dagovic, A
Aleksandrovic, J
Radosavljevic-Asic, G
Citation: B. Jeremic et al., Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: A randomized study, J CL ONCOL, 17(7), 1999, pp. 2092-2099
Authors:
Hayabuchi, N
Shibamoto, Y
Onizuka, Y
Sueyama, H
Fukuhara, N
Niibe, H
Murata, T
Nishida, T
Kishi, K
Kawamura, M
Nakazawa, M
Hirokawa, Y
Nishio, M
Kitahara, T
Sakae, K
Nishijima, H
Imada, H
Takashima, H
Masumoto, H
Yanagawa, S
Chuurei, H
Yokouchi, J
Saitoh, T
Citation: N. Hayabuchi et al., Primary central nervous system lymphoma in Japan: A nationwide survey, INT J RAD O, 44(2), 1999, pp. 265-272
Authors:
Jeremic, B
Shibamoto, Y
Milicic, B
Milisavljevic, S
Nikolic, N
Dagovic, A
Aleksandrovic, J
Radosavljevic-Asic, G
Citation: B. Jeremic et al., A phase II study of concurrent accelerated hyperfractionated radiotherapy and carboplatin/oral etoposide for elderly patients with stage III non-small-cell lung cancer, INT J RAD O, 44(2), 1999, pp. 343-348